Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 16 2021 - 8:30AM
Fluidigm Corporation (Nasdaq:FLDM), an innovative
biotechnology tools provider with a vision to improve life through
comprehensive health insight, today announced that Chris
Linthwaite, President and CEO, and Vikram Jog, Chief Financial
Officer, will participate in investor meetings and present updates
regarding Fluidigm’s business strategy and financial performance at
the following investor event:
- Piper Sandler 33rd Annual Virtual Healthcare Conference. A
pre-recorded fireside chat will be made available on demand Monday,
November 22, 2021, at 10:00 a.m. ET. Management will be available
Tuesday, November 30, 2021, for virtual one-on-one meetings.
A live webcast of the company’s fireside chat and
subsequent replay will be available in the Events &
Presentations section of the Fluidigm® investor website. The
webcast will be archived for 90 days following the live
presentation.
About Fluidigm
Fluidigm (Nasdaq:FLDM) focuses on the most pressing needs in
translational and clinical research, including cancer, immunology,
and immunotherapy. Using proprietary CyTOF® and microfluidics
technologies, we develop, manufacture, and market multi-omic
solutions to drive meaningful insights in health and disease,
identify biomarkers to inform decisions, and accelerate the
development of more effective therapies. Our customers are leading
academic, government, pharmaceutical, biotechnology, plant and
animal research, and clinical laboratories worldwide. Together with
them, we strive to increase the quality of life for all. For more
information, visit fluidigm.com.Fluidigm,
the Fluidigm logo and CyTOF are trademarks and/or
registered trademarks of Fluidigm Corporation or its
affiliates in the United States and/or other
countries. All other trademarks are the sole property of their
respective owners. Fluidigm products are provided for
Research Use Only. Not for use in diagnostic
procedures.
Available InformationWe use our
website (fluidigm.com), investor site (investors.fluidigm.com),
corporate Twitter account (@fluidigm), Facebook page
(facebook.com/Fluidigm), and LinkedIn page
(linkedin.com/company/fluidigm-corporation) as channels of
distribution of information about our products, our planned
financial and other announcements, our attendance at upcoming
investor and industry conferences, and other matters. Such
information may be deemed material information, and we may use
these channels to comply with our disclosure obligations under
Regulation FD. Therefore, investors should monitor our website and
our social media accounts in addition to following our press
releases, SEC filings, public conference calls, and
webcasts.
Contact:
Investors:Peter DeNardo415 389
6400ir@fluidigm.com
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From Sep 2023 to Sep 2024